tak-058
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02153099)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Serotonin 3a (5-HT3a) receptorANTAGONIST
HTR3A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tak-058
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02614586 | Phase 1 | Dec 1, 2015 | Takeda |
| NCT02389881 | Phase 1 | Feb 1, 2015 | Takeda |
| NCT02153099 | Phase 1 | Jun 1, 2014 | Takeda |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takeda | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1